Today, with more companies outsourcing drug manufacturing, the sector has flourished while cleaving along many innovations like data analytics and automation for formulating the most precise therapeutic medicine. The 2019 market report by global healthcare contract manufacturing showed that the proliferation of technologies is improving drug efficiency and shelf life. With a set of comprehensive, integrated services ranging from active pharmaceutical ingredient (API) manufacturing to final dosage form (FDF) manufacturing, the contract manufacturing organizations (CMO) are acquiring a significant seat in the med tech realm.
In addition, the capital-intensive nature of the drug development and manufacturing is inviting attention from more prominent pharma companies keen on research and development of drugs for chronic diseases like cancer and HIV aids. These factors are pushing the growth of the healthcare contract manufacturing market and fueling future opportunities for patients.
In order to assist pharmaceutical companies in the task of finding accomplished CMOs, we have compiled this issue of MedTech Outlook. In this edition, we have listed the top 10 CMOs. Equipped with innovative technological capabilities, these CMOs are set to transform the landscape. This edition also blends through thought leadership articles from subject-matter experts, CIOs, and CXOs, with real-life stories on how the CMOs have enhanced the capabilities of their clients. We hope this issue of MedTech Outlook helps you build the partnership you and your organization need to foster a workspace driven by robust and efficient technology.
We present to you MedTech Outlook’s, “Top 10 Contract Manufacturers – 2020.”
